Literature DB >> 27081180

Unmanipulated haploidentical versus matched unrelated donor allogeneic stem cell transplantation in adult patients with acute myelogenous leukemia in first remission: a retrospective pair-matched comparative study of the Beijing approach with the EBMT database.

Yuqian Sun1, Eric Beohou2, Myriam Labopin3, Liisa Volin4, Noel Milpied5, Ibrahim Yakoub-Agha6, Simona Piemontese7, Emmanuelle Polge2, Mohamed Houhou2, Xiao-Jun Huang8, Mohamad Mohty9, Arnon Nagler10, Norbert-Claude Gorin11.   

Abstract

Entities:  

Keywords:  T-cell repletion; acute myeloid leukemia; adult; haploidentical donor; matched unrelated donor

Mesh：

Year:  2016        PMID： 27081180      PMCID： PMC4967588          DOI： 10.3324/haematol.2015.140509

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  14 in total

1.  T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT.

Authors:  Yi Luo; Haowen Xiao; Xiaoyu Lai; Jimin Shi; Yamin Tan; Jingsong He; Wanzhuo Xie; Weiyan Zheng; Yuanyuan Zhu; Xiujin Ye; Xiaohong Yu; Zhen Cai; Maofang Lin; He Huang
Journal:  Blood       Date:  2014-09-11       Impact factor: 22.113

2.  Low frequency of mutations in Chinese with acute myeloid leukemia: Different disease or different aetiology?

Authors:  Jiawei Yin; Xiaoli Xie; Fan Zhang; Zheng Chen; Chenxi Hu; Guangsong Su; Hong Liu; Yanwen Zheng; Chao He; Hongjie Shen; Qiaocheng Qiu; Jun He; Zhirong Pan; Robert Peter Gale; Depei Wu; Bin Yin
Journal:  Leuk Res       Date:  2015-03-19       Impact factor: 3.156

3.  Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study.

Authors:  Yu Wang; Qi-Fa Liu; Lan-Ping Xu; Kai-Yan Liu; Xiao-Hui Zhang; Xiao Ma; Zhi-Ping Fan; De-Pei Wu; Xiao-Jun Huang
Journal:  Blood       Date:  2015-05-04       Impact factor: 22.113

4.  Patients receiving HLA-haploidentical/partially matched related allo-HSCT can achieve desirable health-related QoL that is comparable to that of patients receiving HLA-identical sibling allo-HSCT.

Authors:  X-D Mo; L-P Xu; D-H Liu; Y-H Chen; W Han; X-H Zhang; H Chen; Y Wang; J-Z Wang; K-Y Liu; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2012-01-09       Impact factor: 5.483

5.  High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease.

Authors:  Leo Luznik; Javier Bolaños-Meade; Marianna Zahurak; Allen R Chen; B Douglas Smith; Robert Brodsky; Carol Ann Huff; Ivan Borrello; William Matsui; Jonathan D Powell; Yvette Kasamon; Steven N Goodman; Allan Hess; Hyam I Levitsky; Richard F Ambinder; Richard J Jones; Ephraim J Fuchs
Journal:  Blood       Date:  2010-02-02       Impact factor: 22.113

6.  T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation.

Authors:  Asad Bashey; Xu Zhang; Connie A Sizemore; Karen Manion; Stacey Brown; H Kent Holland; Lawrence E Morris; Scott R Solomon
Journal:  J Clin Oncol       Date:  2013-02-19       Impact factor: 44.544

Review 7.  Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity.

Authors:  Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Semin Oncol       Date:  2012-12       Impact factor: 4.929

8.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

Review 9.  Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist.

Authors:  Natasha Kekre; Joseph H Antin
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

10.  Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies.

Authors:  Huang Xiao-Jun; Xu Lan-Ping; Liu Kai-Yan; Liu Dai-Hong; Wang Yu; Chen Huan; Chen Yu-Hong; Han Wei; Wang Jing-Zhi; Chen Yao; Zhang Xiao-Hui; Shi Hong-Xia; Wang Feng-Rong; Tang Fei-Fei
Journal:  Clin Cancer Res       Date:  2009-07-07       Impact factor: 12.531
View more
  16 in total

1.  A review of hematopoietic cell transplantation in China: data and trends during 2008-2016.

Authors:  L-P Xu; D-P Wu; M-Z Han; H Huang; Q-F Liu; D-H Liu; Z-M Sun; L-H Xia; J Chen; H-X Wang; C Wang; C-F Li; Y-R Lai; J-M Wang; D-B Zhou; H Chen; Y-P Song; T Liu; K-Y Liu; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2017-04-24       Impact factor: 5.483

2.  Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models.

Authors:  Xueyan Sun; Yan Su; Xiao Liu; Yuanyuan Zhang; Yun He; Wei Han; Qi Chen; Huan Chen; Yu Wang; Yifei Cheng; Fengqi Liu; Fengrong Wang; Yao Chen; Gaochao Zhang; Xiaodong Mo; Haixia Fu; Yuhong Chen; Jingzhi Wang; Xiaolu Zhu; Lanping Xu; Kaiyan Liu; Xiaojun Huang; Xiaohui Zhang
Journal:  Bone Marrow Transplant       Date:  2021-01-07       Impact factor: 5.483

3.  Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

Authors:  Armin Rashidi; Mehdi Hamadani; Mei-Jie Zhang; Hai-Lin Wang; Hisham Abdel-Azim; Mahmoud Aljurf; Amer Assal; Ashish Bajel; Asad Bashey; Minoo Battiwalla; Amer M Beitinjaneh; Nelli Bejanyan; Vijaya Raj Bhatt; Javier Bolaños-Meade; Michael Byrne; Jean-Yves Cahn; Mitchell Cairo; Stefan Ciurea; Edward Copelan; Corey Cutler; Andrew Daly; Miguel-Angel Diaz; Nosha Farhadfar; Robert P Gale; Siddhartha Ganguly; Michael R Grunwald; Theresa Hahn; Shahrukh Hashmi; Gerhard C Hildebrandt; H Kent Holland; Nasheed Hossain; Christopher G Kanakry; Mohamed A Kharfan-Dabaja; Nandita Khera; Yener Koc; Hillard M Lazarus; Jong-Wook Lee; Johan Maertens; Rodrigo Martino; Joseph McGuirk; Reinhold Munker; Hemant S Murthy; Ryotaro Nakamura; Sunita Nathan; Taiga Nishihori; Neil Palmisiano; Sagar Patel; Joseph Pidala; Rebecca Olin; Richard F Olsson; Betul Oran; Olov Ringden; David Rizzieri; Jacob Rowe; Mary Lynn Savoie; Kirk R Schultz; Sachiko Seo; Brian C Shaffer; Anurag Singh; Melhem Solh; Keith Stockerl-Goldstein; Leo F Verdonck; John Wagner; Edmund K Waller; Marcos De Lima; Brenda M Sandmaier; Mark Litzow; Dan Weisdorf; Rizwan Romee; Wael Saber
Journal:  Blood Adv       Date:  2019-06-25

4.  Haploidentical transplant in patients with myelodysplastic syndrome.

Authors:  Marie Robin; Raphael Porcher; Fabio Ciceri; Maria Teresa van Lint; Stella Santarone; Gerhard Ehninger; Didier Blaise; Zafer Güllbas; Soledad Gonzáles Muñiz; Mauricette Michallet; Andrea Velardi; Linda Koster; Johan Maertens; Jorge Sierra; Dominik Selleslag; Aleksandar Radujkovic; José L Díez-Martin; Lothar Kanz; Concepcion Herrera Arroyo; Dietger Niederwieser; He Huang; Andrew McDonald; Theo de Witte; Yener Koc; Nicolaus Kröger
Journal:  Blood Adv       Date:  2017-09-27

Review 5.  The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.

Authors:  Lanping Xu; Hu Chen; Jing Chen; Mingzhe Han; He Huang; Yongrong Lai; Daihong Liu; Qifa Liu; Ting Liu; Ming Jiang; Hanyun Ren; Yongping Song; Zimin Sun; Jianmin Wang; Depei Wu; Daobin Zhou; Ping Zou; Kaiyan Liu; Xiaojun Huang
Journal:  J Hematol Oncol       Date:  2018-03-02       Impact factor: 17.388

Review 6.  A review of infectious complications after haploidentical hematopoietic stem cell transplantations.

Authors:  Erden Atilla; Pinar Ataca Atilla; Sinem Civriz Bozdağ; Taner Demirer
Journal:  Infection       Date:  2017-04-17       Impact factor: 3.553

Review 7.  Update of the "Beijing Protocol" haplo-identical hematopoietic stem cell transplantation.

Authors:  Meng Lv; Ying-Jun Chang; Xiao-Jun Huang
Journal:  Bone Marrow Transplant       Date:  2019-08       Impact factor: 5.483

8.  Haploidentical stem cell transplantation (HaploSCT) for patients with acute leukemia-an update on behalf of the ALWP of the EBMT.

Authors:  Arnon Nagler; Annalisa Ruggeri
Journal:  Bone Marrow Transplant       Date:  2019-08       Impact factor: 5.483

Review 9.  Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Authors:  Catherine J Lee; Bipin N Savani; Mohamad Mohty; Myriam Labopin; Annalisa Ruggeri; Christoph Schmid; Frédéric Baron; Jordi Esteve; Norbert C Gorin; Sebastian Giebel; Fabio Ciceri; Arnon Nagler
Journal:  Haematologica       Date:  2017-09-07       Impact factor: 9.941

10.  [Impact of mycophenolate mofetil prophylaxis duration on acute graft-versus-host disease after haploidentical stem cell transplantation].

Authors:  Y Q Sun; X J Huang; L P Xu; X H Zhang; C H Yan; K Y Liu; Y Wang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.